Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 09 Dec 2025 for COLLEGIUM PHARMACEUTICAL, INC, €147k. Read the official filing
Filing timeline
BuySaleRita J. Balice-Gordon
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Rita J. Balice-Gordon: trading record in brief
All filings by Rita J. Balice-Gordon on record concern Collegium Pharmaceutical, Inc, in the capacity of board member. Between 20 May 2021 and 5 December 2025, the trades on record add up to 6 filings.
The open-market record consists of 1 sale worth €147k, with no purchase. Besides market trades, the filings include 5 share grants. Since January 2025: no purchases and 1 sale on the market.
On 9 December 2025 came the latest disclosure, an open-market sale for €147k in Collegium Pharmaceutical, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Rita J. Balice-Gordon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,650 shares@ US$47.0338100.0% of flowCommon StockSEC:0001825625-25-000004:0
9,791 shares0Common StockSEC:0001062993-25-009807:0
7,693 shares0Common StockSEC:0001062993-24-010538:0
9,792 shares0Common StockSEC:0001062993-23-011821:0
14,035 shares0Common StockSEC:0001062993-22-013299:0
9,941 shares0Common StockSEC:0001192482-21-000458:0
6 of 6 declarations
